Barriers for conducting clinical trials in develo** countries-a systematic review
Background Clinical trials for identification of efficient and effective new diagnostic and
treatment modalities are needed to address disproportionately high burden of …
treatment modalities are needed to address disproportionately high burden of …
Health research capacity development in low and middle income countries: reality or rhetoric? A systematic meta-narrative review of the qualitative literature
SRP Franzen, C Chandler, T Lang - BMJ open, 2017 - bmjopen.bmj.com
Objectives Locally led health research in low and middle income countries (LMICs) is critical
for overcoming global health challenges. Yet, despite over 25 years of international efforts …
for overcoming global health challenges. Yet, despite over 25 years of international efforts …
Decolonising global health: transnational research partnerships under the spotlight
DS Lawrence, LA Hirsch - International health, 2020 - academic.oup.com
There are increasing calls to decolonise aspects of science, and global health is no
exception. The decolonising global health movement acknowledges that global health …
exception. The decolonising global health movement acknowledges that global health …
Design and conduct considerations for first‐in‐human trials
J Shen, B Swift, R Mamelok, S Pine… - Clinical and …, 2019 - Wiley Online Library
A milestone step in translational science to transform basic scientific discoveries into
therapeutic applications is the advancement of a drug candidate from preclinical studies to …
therapeutic applications is the advancement of a drug candidate from preclinical studies to …
[HTML][HTML] Clinical trials have gone global: is this a good thing?
Clinical Trials Have Gone Global: Is This a Good Thing? | PLOS Medicine Skip to main content
Advertisement PLOS Medicine Browse Current Issue Journal Archive Special Issues Collections …
Advertisement PLOS Medicine Browse Current Issue Journal Archive Special Issues Collections …
Strategies for develo** sustainable health research capacity in low and middle-income countries: a prospective, qualitative study investigating the barriers and …
SRP Franzen, C Chandler, S Siribaddana, J Atashili… - BMJ open, 2017 - bmjopen.bmj.com
Objectives In 2013, the WHO stated that unless low-income and middle-income countries
(LMICs) become producers of research, health goals would be hard to achieve. Among the …
(LMICs) become producers of research, health goals would be hard to achieve. Among the …
Advancing global health research through digital technology and sharing data
T Lang - Science, 2011 - science.org
The imperative for improving health in the world's poorest regions lies in research, yet there
is no question that low participation, a lack of trained staff, and limited opportunities for data …
is no question that low participation, a lack of trained staff, and limited opportunities for data …
Critical care outcomes in resource-limited settings
Outcomes from HICs cannot be reliably extrapolated to LMICs, so it is important to study
outcomes for critically ill patients in LMICs. Specific challenges to achieving meaningful …
outcomes for critically ill patients in LMICs. Specific challenges to achieving meaningful …
Perinatal distress in women in low-and middle-income countries: allostatic load as a framework to examine the effect of perinatal distress on preterm birth and infant …
S Premji - Maternal and Child Health Journal, 2014 - Springer
In low-and middle-income countries (LMIC), determinants of women's and children's health
are complex and differential vulnerability may exist to risk factors of perinatal distress and …
are complex and differential vulnerability may exist to risk factors of perinatal distress and …
The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator …
Conducting clinical trials in develo** countries often presents significant ethical,
organisational, cultural and infrastructural challenges to researchers, pharmaceutical …
organisational, cultural and infrastructural challenges to researchers, pharmaceutical …